Literature DB >> 1318912

Subclinical central nervous system infection with JC virus in patients with AIDS.

E B Quinlivan1, M Norris, T W Bouldin, K Suzuki, R Meeker, M S Smith, C Hall, S Kenney.   

Abstract

Immunocompromised patients, particularly those with AIDS, develop progressive multifocal leukoencephalopathy (PML) due to central nervous system infection with JC virus (JCV). It is unknown whether JCV infection in the central nervous system can occur in the absence of PML symptoms. To address this question, autopsy specimens from patients with AIDS were examined. The brains of a group of patients without AIDS or central nervous system disease were also examined. JCV DNA was detected by the polymerase chain reaction in brain tissue from 4 (31%) of 13 human immunodeficiency virus (HIV)-positive patients. JCV was also detected in 1 elderly HIV-negative patient but not in the 11 other control brains. JCV was not detected in 22 myocardial specimens obtained at autopsy from HIV-negative patients nor 10 peripheral blood specimens from HIV-positive patients. The presence of JCV in brains of patients without clinically evident PML suggests that JCV may be present in the central nervous system without clinical disease.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1318912     DOI: 10.1093/infdis/166.1.80

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  12 in total

1.  Inflammatory reaction in progressive multifocal leukoencephalopathy: harmful or beneficial?

Authors:  Renaud A Du Pasquier; Igor J Koralnik
Journal:  J Neurovirol       Date:  2003       Impact factor: 2.643

2.  Dual qualitative-quantitative nested PCR for detection of JC virus in cerebrospinal fluid: high potential for evaluation and monitoring of progressive multifocal leukoencephalopathy in AIDS patients receiving highly active antiretroviral therapy.

Authors:  D García de Viedma; R Alonso; P Miralles; J Berenguer; M Rodriguez-Créixems; E Bouza
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

3.  Diagnostic value of detecting JC virus DNA in cerebrospinal fluid of patients with progressive multifocal leukoencephalopathy.

Authors:  I W Fong; C B Britton; K E Luinstra; E Toma; J B Mahony
Journal:  J Clin Microbiol       Date:  1995-02       Impact factor: 5.948

4.  Persistent JC virus (JCV) infection is demonstrated by continuous shedding of the same JCV strains.

Authors:  T Kitamura; C Sugimoto; A Kato; H Ebihara; M Suzuki; F Taguchi; K Kawabe; Y Yogo
Journal:  J Clin Microbiol       Date:  1997-05       Impact factor: 5.948

Review 5.  The role of polyomaviruses in human disease.

Authors:  Mengxi Jiang; Johanna R Abend; Silas F Johnson; Michael J Imperiale
Journal:  Virology       Date:  2008-11-07       Impact factor: 3.616

Review 6.  Opportunistic infections of the CNS in patients with AIDS: diagnosis and management.

Authors:  Julio Collazos
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

7.  Detection of BK virus DNA in nasopharyngeal aspirates from children with respiratory infections but not in saliva from immunodeficient and immunocompetent adult patients.

Authors:  A Sundsfjord; A R Spein; E Lucht; T Flaegstad; O M Seternes; T Traavik
Journal:  J Clin Microbiol       Date:  1994-05       Impact factor: 5.948

8.  PML-IRIS in patients with HIV infection: clinical manifestations and treatment with steroids.

Authors:  K Tan; R Roda; L Ostrow; J McArthur; A Nath
Journal:  Neurology       Date:  2009-01-07       Impact factor: 9.910

9.  JC polyomavirus infection in candidates for kidney transplantation living in the Brazilian Amazon region.

Authors:  Fernando Assis Ferreira Melo; Ana Caroline Fonseca Bezerra; Bárbara Brasil Santana; Marluísa Oliveira Guimarães Ishak; Ricardo Ishak; Izaura Maria Vieira Cayres-Vallinoto; Antonio Carlos Rosário Vallinoto
Journal:  Mem Inst Oswaldo Cruz       Date:  2013-04       Impact factor: 2.743

10.  Infection of glial cells by the human polyomavirus JC is mediated by an N-linked glycoprotein containing terminal alpha(2-6)-linked sialic acids.

Authors:  C K Liu; G Wei; W J Atwood
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.